The decarboxylation process is essential to enjoying edibles and cannabis flowers. It is the release of carbon dioxide from a stable molecule. The atoms of a molecule are like billiard ball, as each one has a specific size, mass, and position. These atoms will float off, leaving behind a lighter substance. This is similar to comparing a wet towel with a dried towel. As the CO2 leaves the atmosphere, it is thought that the remaining weight will be reduced.
The most common way to cause decarboxylation is by heating. However, it can also occur by exposure of certain light frequencies and substances such as molecular oxygen.
Calculate the percent mass loss in decarboxylation if you know the weights of the molecules before and after decarboxylation. Decarboxylation is 90 percent effective if CO2 makes up 10 percent of a molecular weight. This means that by continuously heating this substance to 90 grams, the CO2 will eventually gas off.
Can Decarboxylation Effect Cannabinoids
Understanding the medicinal power of marijuana is dependent on decarboxylation. THC, which is produced outside of the plant, can only be created through decarboxylation. The decarboxylation process is typically done with fire, when smoking or in the baking of edibles. Decarboxylation causes cannabinoids to lose approximately 87.7% of their mass. Decarboxylation would leave 87.7 g of THC if 100 gram of a crystalline cannabinoid, like THCA was used.
Decarboxylated hash oils and edibles, as well as those decarboxylating cannabinoids by themselves (such a producers), will need to know this information. Advertisers of raw cannabis products, like cured cannabis flowers, must also report on the amount of cannabinoid-acid directly measured by testing laboratories, the theoretical conversion or both.
It’s not so simple to label raw flowers as first appears. Consider a cannabis strain that is THC dominant. A lab tests the flower, finding 26 percent of THCA with 3 percent of THC. The reason for this is that some cannabinoid acid produced by the plants are decarboxylated before the harvest and curing. A lower THC concentration observed by the laboratory indicates that fresh cannabis was submitted that had been shielded from exposure and light. The presence of a high THC level indicates the flower has been exposed to light and is less fresh.
The dispensary can either choose to advertise two percentages, such as 26 and 3 percent or one calculated theoretically, 25,8 percent. Or they can do both. This allows the patient the opportunity to be well informed and have access to the maximum amount of information. It also helps the cannabis businesses reduce their liability.
Tetrahydrocannabinol is the main intoxicant, euphoriant, and psychoactive component of cannabis. THC has been shown to be a safe and effective treatment for chronic and neuropathic types of pain.. THC can be used to treat both immunological symptoms and multiple sclerosis.
THCA has a strong medicinal effect, despite not being intoxicating. THCA has one of the most powerful anti-inflammatory properties in cannabis. Due to the decomposition of cannabinoid during smoking, smokers receive little or no cannabinoid. THCA has anti-inflammatory properties and, according to a study, is a stronger neuroprotective than THC. THCA has a similar effect to aspirin or ibuprofen but is less toxic to the liver.
The diverse actions of THCA/THC on the body of a human can be seen in the action of cannabinoid precursors and cannabinoids. All the other cannabinoids – CBD, CBG CBC and THCV – have their own acid form that has distinct effects on health.
Cannabidiol CBD has shown to be a powerful medicine in the treatment of anxiety. CBD also has been proven to fight breast cancer. In many of these studies, CBD is found to promote apoptosis or cell suicide in breast cancerous cells, while leaving healthy cells unaffected.
Cannabidiolic acids CBDA is the acid precursor of CBD derived from raw cannabis flowers. CBDA also has been proven to combat human breast cancer in a slightly different manner. CBDA is able to stop or slow the spread of breast tumor cells. This occurs by stopping their ability to travel throughout the body. The evidence suggests that breast cancer patients may wish to discuss with their doctors the possibility of a dual CBD/CBDA treatment, which involves taking decarboxylated CBD along with raw CBDA.
Cannabigerol CBG has shown some powerful anti-inflammatory effects that can be applied to inflammatory bowel diseases (IBS). CBG also has some unique properties that are not found in other cannabinoids. These include the ability to interact both with human serotonin and adrenal receptors. More studies are needed to understand the difference between cannabigerolic (CBGA), a precursor to CBG, and CBG.
The mass loss rate is different from the conversion rate. The mass loss is calculated by assuming that the entire substance will decarboxylate. To get an accurate answer, you must know how much cannabinoid is decarboxylated. According to studies, 30-70 percent cannabinoids decarboxylate under normal smoking conditions. It is for this reason that our calculations only represent the theoretical maximum and do not reflect the results directly observed by the plant. As a way to limit your company’s liability, it is very important to clearly label theoretical calculations.